Literature DB >> 18544074

Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome.

J-M Sabate1, M Veyrac, F Mion, L Siproudhis, P Ducrotte, F Zerbib, J-C Grimaud, M Dapoigny, F Dyard, B Coffin.   

Abstract

BACKGROUND: Relationships between pain threshold during rectal distension and both symptoms intensity and alteration in quality of life (QoL) in irritable bowel syndrome (IBS) patients have been poorly evaluated. AIM: To evaluate relationships between rectal sensitivity, IBS symptom intensity and QoL in a multicentre prospective study.
METHODS: Rectal threshold for moderate pain was measured during rectal distension in IBS patients (Rome II), while IBS symptoms intensity was assessed by a validated questionnaire and QoL by the Functional Digestive Disorder Quality of Life questionnaire.
RESULTS: Sixty-eight patients (44.2 +/- 12.7 years, 48 women) were included. The mean rectal distending volume for moderate pain was 127 +/- 35 mL while 45 patients (66%) had rectal hypersensitivity (pain threshold <140 mL). Rectal threshold was not significantly related either to overall IBS intensity score (r = -0.66, P = 0.62) or to its different components, or to FDDQL score (r = 0.30, P = 0.14). Among FDDQL domains, only anxiety (r = 0.30, P = 0.01) and coping (r = 0.31, P = 0.009) were significantly related with pain threshold.
CONCLUSIONS: In this study, two-thirds of IBS patients exhibited rectal hypersensitivity. No significant correlation was found between rectal threshold and either symptom intensity or alteration in QoL.

Entities:  

Mesh:

Year:  2008        PMID: 18544074      PMCID: PMC2696685          DOI: 10.1111/j.1365-2036.2008.03759.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  28 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  A systematic review of neuroimaging data during visceral stimulation.

Authors:  Stuart W G Derbyshire
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

3.  Health-related quality of life among persons with irritable bowel syndrome: a systematic review.

Authors:  H B El-Serag; K Olden; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2002-06       Impact factor: 8.171

4.  Evolution of visceral sensitivity in patients with irritable bowel syndrome.

Authors:  Pierre Poitras; Monique Riberdy Poitras; Victor Plourde; Michel Boivin; Pierre Verrier
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

5.  What determines severity among patients with painful functional bowel disorders?

Authors:  D A Drossman; W E Whitehead; B B Toner; N Diamant; Y J Hu; S I Bangdiwala; H Jia
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

6.  Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation.

Authors:  J-M Sabaté; D Bouhassira; C Poupardin; A Wagner; Y Loria; B Coffin
Journal:  Neurogastroenterol Motil       Date:  2007-11-14       Impact factor: 3.598

7.  Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome.

Authors:  A Prior; N W Read
Journal:  Aliment Pharmacol Ther       Date:  1993-04       Impact factor: 8.171

8.  Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects.

Authors:  M Bradette; M Delvaux; G Staumont; J Fioramonti; L Bueno; J Frexinos
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

9.  Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation.

Authors:  Miguel Minguez; Belen Herreros; Vicente Sanchiz; Vicent Hernandez; Pedro Almela; Ramon Añon; Francisco Mora; Adolfo Benages
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

10.  Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome.

Authors:  Benoit Coffin; Michel Dapoigny; Denis Cloarec; Denis Comet; François Dyard
Journal:  Gastroenterol Clin Biol       Date:  2004-01
View more
  15 in total

Review 1.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 2.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

3.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

4.  Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance.

Authors:  Geng Qin; Yu Zhang; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

5.  Thermal hypersensitivity in a subset of irritable bowel syndrome patients.

Authors:  Qiqi Zhou; Roger B Fillingim; Joseph L Riley; G Nicholas Verne
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

6.  Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Buyi Zhang; G Nicholas Verne
Journal:  Pain       Date:  2009-11       Impact factor: 6.961

Review 7.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Ischemic hypersensitivity in irritable bowel syndrome patients.

Authors:  Qiqi Zhou; Roger B Fillingim; Joseph L Riley; G Nicholas Verne
Journal:  Pain Med       Date:  2010-10-01       Impact factor: 3.750

9.  Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.

Authors:  Michel Dapoigny; Thierry Piche; Philippe Ducrotte; Bernard Lunaud; Jean-Michel Cardot; Annick Bernalier-Donadille
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

10.  Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Ji-Meng Zhao; Lu-Yi Wu; Hui-Rong Liu; Hong-Yi Hu; Jia-Ying Wang; Ren-Jia Huang; Yin Shi; Shan-Ping Tao; Qiang Gao; Ci-Li Zhou; Li Qi; Xiao-Peng Ma; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.